GENE ONLINE|News &
An Interview with Dr. Daixing Zhou, the Pioneer of Genetic Testing, on the Genetic Market in China
Dr. Daixing Zhou is the key driving force of China's Non-Invasive Prenatal Testing (NIPT), and also the pioneer of the Chinese genetic testing market. Making a living away from home in the United States for twenty years, his earlier work in DNA microarrays laid a solid foundation for his transition into the high-throughput sequencing technology field. In 2007, Dr. Zhou was inspired by the “Intrauterine cell-free fetal DNA” research done by Professor Dennis Lo, thus entered the NIPT field and established Berry Genomics in Beijing, China later in 2010, which focused on the clinical application transformation of NGS. Dr. Zhou has penetrative observation and distinctive insights on the genetic testing market in China:
It's free! Log in now to read
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
